935 related articles for article (PubMed ID: 22116819)
1. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
2. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
3. Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model.
Okamura H; Emrich F; Trojan J; Chiu P; Dalal AR; Arakawa M; Sato T; Penov K; Koyano T; Pedroza A; Connolly AJ; Rabinovitch M; Alvira C; Fischbein MP
Physiol Rep; 2017 Apr; 5(8):. PubMed ID: 28455451
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
[TBL] [Abstract][Full Text] [Related]
5. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
[TBL] [Abstract][Full Text] [Related]
6. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
7. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
12. Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation.
Emrich F; Penov K; Arakawa M; Dhablania N; Burdon G; Pedroza AJ; Koyano TK; Kim YM; Raaz U; Connolly AJ; Iosef C; Fischbein MP
J Cell Mol Med; 2019 Oct; 23(10):7000-7009. PubMed ID: 31402541
[TBL] [Abstract][Full Text] [Related]
13. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Habashi JP; Judge DP; Holm TM; Cohn RD; Loeys BL; Cooper TK; Myers L; Klein EC; Liu G; Calvi C; Podowski M; Neptune ER; Halushka MK; Bedja D; Gabrielson K; Rifkin DB; Carta L; Ramirez F; Huso DL; Dietz HC
Science; 2006 Apr; 312(5770):117-21. PubMed ID: 16601194
[TBL] [Abstract][Full Text] [Related]
14. The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
Wisler JW; Harris EM; Raisch M; Mao L; Kim J; Rockman HA; Lefkowitz RJ
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1516-27. PubMed ID: 26371162
[TBL] [Abstract][Full Text] [Related]
15. The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.
Verbrugghe P; Verhoeven J; Clijsters M; Vervoort D; Schepens J; Meuris B; Herijgers P
J Cardiovasc Pharmacol; 2018 Apr; 71(4):215-222. PubMed ID: 29300219
[TBL] [Abstract][Full Text] [Related]
16. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
[TBL] [Abstract][Full Text] [Related]
18. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
[TBL] [Abstract][Full Text] [Related]
19. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
[TBL] [Abstract][Full Text] [Related]
20. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
